Common Stock, Shares, Outstanding of Applied Therapeutics, Inc. from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Applied Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2018 to Q3 2025.
  • Applied Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 144M shares, a 24% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Applied Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 144M +27.9M +24% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 142M +27.1M +23.6% 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 142M +27.3M +23.9% 31 Mar 2025 10-Q 14 May 2025
Q4 2024 137M +52.4M +61.7% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 116M +39.2M +50.9% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 115M +52.7M +84.9% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 114M +66.1M +137% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 84.9M +36.8M +76.6% 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 77.1M +29.1M +60.5% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 62.1M +15.9M +34.3% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 48.1M +21.9M +83.5% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 48.1M +21.8M +83.3% 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 48.1M +21.8M +83.3% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 46.3M +20.1M +77% 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 26.2M +205K +0.79% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 26.2M +3.72M +16.5% 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 26.2M +3.76M +16.7% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 26.1M +3.8M +17% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 26M +4.04M +18.4% 31 Mar 2021 10-Q 11 May 2021
Q4 2020 22.5M +3.96M +21.4% 31 Dec 2020 10-K 10 Mar 2022
Q3 2020 22.5M +5.32M +31.1% 30 Sep 2020 10-Q 12 Nov 2020
Q2 2020 22.3M +5.28M +31% 30 Jun 2020 10-Q 11 Aug 2020
Q1 2020 22M +16.5M +298% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 18.5M +13M +236% 31 Dec 2019 10-K 18 Mar 2021
Q3 2019 17.1M 30 Sep 2019 10-Q 13 Nov 2019
Q2 2019 17.1M 30 Jun 2019 10-Q 12 Aug 2019
Q1 2019 5.51M 31 Mar 2019 10-Q 21 Jun 2019
Q4 2018 5.51M 31 Dec 2018 10-K 13 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.